3,122
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of antioxidant and hepatoprotective effects of white cabbage essential oil

, , , , , & show all
Pages 233-241 | Received 04 Nov 2015, Accepted 03 Nov 2016, Published online: 07 Dec 2016

Figures & data

Table 1. Major components of B. oleracea var. capitata F. alba essential oil (Bocfal EO) obtained by hydrodistillation at low pressure (200–150 mmHg) and low temperature (55–58 °C) conditions.

Table 2. Antioxidant activity by TBARS assay.

Figure 1. Plasma cholestasis markers: enzyme activities of alkaline phosphatase (AP) and γ-glutamyl transpeptidase (GGTP); total bilirubin determined in the plasma from control rats treated with their respective vehicles (VE + VTC), with Bocfal EO (Bocfal EO + VCT) or with DADS (DADS + VCT) as well as those administered the hepatotoxicant CT (VE + CT) but treated with the same compound, respectively (Bocfal EO + CT and DADS + CT). Each bar represents the mean value of experiments performed in duplicate with samples from at least four animals ± SEM. (a) Difference from the VE + VCT group and (b) from the VE + CT group, p < 0.05, Student–Newman–Keuls test.

Figure 1. Plasma cholestasis markers: enzyme activities of alkaline phosphatase (AP) and γ-glutamyl transpeptidase (GGTP); total bilirubin determined in the plasma from control rats treated with their respective vehicles (VE + VTC), with Bocfal EO (Bocfal EO + VCT) or with DADS (DADS + VCT) as well as those administered the hepatotoxicant CT (VE + CT) but treated with the same compound, respectively (Bocfal EO + CT and DADS + CT). Each bar represents the mean value of experiments performed in duplicate with samples from at least four animals ± SEM. (a) Difference from the VE + VCT group and (b) from the VE + CT group, p < 0.05, Student–Newman–Keuls test.

Figure 2. Plasma and liver markers of necrosis, functionality and oxidative stress: alanine aminotransferase enzyme activity (ALT) determined in the plasma, hepatic levels of lipid peroxidation (LP) and glycogen, and catalase activity (CAT) quantified in the livers of control rats treated with their respective vehicles (VE + VTC), with Bocfal EO (Bocfal EO + VCT) or with DADS (DADS + VCT) as well as those administered the hepatotoxicant CT (VE + CT) but treated with the same compound, respectively (Bocfal EO + CT and DADS + CT). Each bar represents the mean value of experiments performed in duplicate with samples from at least four animals ± SEM. (a) Difference from the VE + VCT group and (b) from the VE + CT group, p < 0.05, Student–Newman–Keuls test.

Figure 2. Plasma and liver markers of necrosis, functionality and oxidative stress: alanine aminotransferase enzyme activity (ALT) determined in the plasma, hepatic levels of lipid peroxidation (LP) and glycogen, and catalase activity (CAT) quantified in the livers of control rats treated with their respective vehicles (VE + VTC), with Bocfal EO (Bocfal EO + VCT) or with DADS (DADS + VCT) as well as those administered the hepatotoxicant CT (VE + CT) but treated with the same compound, respectively (Bocfal EO + CT and DADS + CT). Each bar represents the mean value of experiments performed in duplicate with samples from at least four animals ± SEM. (a) Difference from the VE + VCT group and (b) from the VE + CT group, p < 0.05, Student–Newman–Keuls test.

Figure 3. Haematoxylin/eosin staining of representative liver sections from: (A) normal control rats administered vehicle (VE + VCT); (B) damaged control rats administered CT (VE + CT); (C) control rats administered Bocfal EO (Bocfal EO + VCT); (D) damaged rats administered Bocfal EO (Bocfal EO + CT); (E) control rats administered DADS (DADS + VCT) and (F) damaged rats administered DADS (DADS + CT). Central vein (CV), original magnification: 10×.

Figure 3. Haematoxylin/eosin staining of representative liver sections from: (A) normal control rats administered vehicle (VE + VCT); (B) damaged control rats administered CT (VE + CT); (C) control rats administered Bocfal EO (Bocfal EO + VCT); (D) damaged rats administered Bocfal EO (Bocfal EO + CT); (E) control rats administered DADS (DADS + VCT) and (F) damaged rats administered DADS (DADS + CT). Central vein (CV), original magnification: 10×.